YI LING CHAO: Open Payments
NPI 1790267094 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,247 in 86 payments from 16 companies in 2025. Trend: 2023 $1,058 · 2024 $617 · 2025 $2,247
Food & beverage: $2,143Education: $104
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 17 | $516 |
| GENZYME CORPORATION | 15 | $495 |
| Galderma Laboratories, L.P. | 19 | $330 |
| Incyte Corporation | 10 | $191 |
| Regeneron Healthcare Solutions, Inc. | 4 | $188 |
| Novartis Pharmaceuticals Corporation | 5 | $133 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Arcutis Biotherapeutics, Inc. | 4 | $83 |
| Lilly USA, LLC | 2 | $51 |
| Organon LLC | 2 | $36 |
Products named: DUPIXENT, ADBRY, NEMLUVIO, OPZELURA, ANZUPGO, COSENTYX, Zoryve, VTAMA.
Industry payments across NY — which companies pay providers there.
